Yes, testing estrogen after menopause is useful — especially if you are on HRT. Postmenopausal estradiol levels are low but measurable, and tracking them confirms that your HRT dose is producing adequate levels. In perimenopause, estrogen fluctuates widely and a single test may be misleading, but serial testing combined with symptom tracking is still informative.
The confusion around estrogen testing comes from the fact that hormone testing has different value at different stages:
Perimenopause: Estradiol levels can swing dramatically — from low to high to low within weeks. A single blood draw may catch a “normal” value on a day when levels happen to be adequate, missing the overall declining trend. This is why some providers say “testing does not help in perimenopause.” A more accurate statement is: a single test is often insufficient — serial testing combined with symptom assessment provides a clearer picture.
Postmenopause (not on HRT): Estradiol levels are consistently low — typically below 20 pg/mL. Testing confirms postmenopausal status and provides a baseline if you are considering HRT.
Postmenopause (on HRT): This is where testing is most valuable. Monitoring estradiol levels while on HRT confirms that your dose is producing adequate levels (generally 50-200 pg/mL for most women on transdermal estrogen, though targets vary). It also helps your provider adjust the dose if levels are too high (increasing side effect risk) or too low (not providing adequate symptom relief).
Other hormones to test alongside estrogen:
- Progesterone (if on oral progesterone — to confirm absorption)
- Testosterone (total and free)
- SHBG
- Thyroid panel
- FSH (confirms menopausal status)